Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
AdAlta Ltd. ( (AU:1AD) ) has issued an update.
AdAlta Ltd. announced the quotation of 153,657,204 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of October 20, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the accessibility and visibility of its securities.
More about AdAlta Ltd.
AdAlta Ltd. operates in the biotechnology industry, focusing on the development of novel therapeutic products. The company is known for its proprietary i-body technology, which is used to develop treatments for a range of diseases, including fibrosis and cancer.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$4.61M
See more data about 1AD stock on TipRanks’ Stock Analysis page.
Trending Articles:
- RTO Doesn’t Always Mean RTO: Microsoft Stock (NASDAQ:MSFT) Notches Up as Salespeople Find Exemption
- This Was Not the First Bid: Warner Bros. Discovery Stock (NASDAQ:WBD) Gains as it Rejected Three Bids from Paramount So Far
- ‘Paramount Can Walk Away with Warner Bros.’ Say TD Cowen and Benchmark Analysts